| Vincenzo Giannelli, MD | |
|
2440 M St Nw Ste 313, Washington, DC 20037-1449 | |
| (202) 775-1792 | |
| (202) 775-0494 |
| Full Name | Vincenzo Giannelli |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 39 Years |
| Location | 2440 M St Nw Ste 313, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205881182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | MD20747 (District Of Columbia) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Forefront Dermatology | 3779471701 | 483 |
News Archive
By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses.
Every two seconds, someone in the United States is in need of blood. According to the American Red Cross, more than 38,000 blood donations are needed each day. With just one donation of a pint of blood, up to three lives can be saved. In New Jersey, according to the state Department of Health and Senior Services, fewer than four percent of eligible residents donate regularly, resulting in the need for critical blood donations.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiaries Shire Development Inc. and Shire Pharmaceutical Development Inc. have filed a lawsuit in the U.S. District Court for the District of Delaware against Cadila Healthcare Limited, doing business as Zydus Cadila and Zydus Pharmaceuticals, Inc. for the infringement of U.S. Patent No. 6,773,720.
University of Alberta researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.
› Verified 6 days ago
| Entity Name | Dermatology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033390695 PECOS PAC ID: 9739110560 Enrollment ID: O20050822001092 |
News Archive
By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses.
Every two seconds, someone in the United States is in need of blood. According to the American Red Cross, more than 38,000 blood donations are needed each day. With just one donation of a pint of blood, up to three lives can be saved. In New Jersey, according to the state Department of Health and Senior Services, fewer than four percent of eligible residents donate regularly, resulting in the need for critical blood donations.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiaries Shire Development Inc. and Shire Pharmaceutical Development Inc. have filed a lawsuit in the U.S. District Court for the District of Delaware against Cadila Healthcare Limited, doing business as Zydus Cadila and Zydus Pharmaceuticals, Inc. for the infringement of U.S. Patent No. 6,773,720.
University of Alberta researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.
› Verified 6 days ago
| Entity Name | Forefront Dermatology Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1891169975 PECOS PAC ID: 3779471701 Enrollment ID: O20160421001476 |
News Archive
By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses.
Every two seconds, someone in the United States is in need of blood. According to the American Red Cross, more than 38,000 blood donations are needed each day. With just one donation of a pint of blood, up to three lives can be saved. In New Jersey, according to the state Department of Health and Senior Services, fewer than four percent of eligible residents donate regularly, resulting in the need for critical blood donations.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiaries Shire Development Inc. and Shire Pharmaceutical Development Inc. have filed a lawsuit in the U.S. District Court for the District of Delaware against Cadila Healthcare Limited, doing business as Zydus Cadila and Zydus Pharmaceuticals, Inc. for the infringement of U.S. Patent No. 6,773,720.
University of Alberta researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Vincenzo Giannelli, MD 801 York St, Manitowoc, WI 54220-4630 Ph: (920) 663-9035 | Vincenzo Giannelli, MD 2440 M St Nw Ste 313, Washington, DC 20037-1449 Ph: (202) 775-1792 |
News Archive
By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses.
Every two seconds, someone in the United States is in need of blood. According to the American Red Cross, more than 38,000 blood donations are needed each day. With just one donation of a pint of blood, up to three lives can be saved. In New Jersey, according to the state Department of Health and Senior Services, fewer than four percent of eligible residents donate regularly, resulting in the need for critical blood donations.
Shire plc, the global specialty biopharmaceutical company, announces that its subsidiaries Shire Development Inc. and Shire Pharmaceutical Development Inc. have filed a lawsuit in the U.S. District Court for the District of Delaware against Cadila Healthcare Limited, doing business as Zydus Cadila and Zydus Pharmaceuticals, Inc. for the infringement of U.S. Patent No. 6,773,720.
University of Alberta researchers have taken another step forward in developing an artificial intelligence tool to predict schizophrenia by analyzing brain scans.
› Verified 6 days ago
Dr. George Walter Turiansky, MD Dermatology Medicare: Medicare Enrolled Practice Location: Walter Reed Army Medical Center; Attn: Mchl-mao-c, 6900 Georgia Ave. Nw, Washington, DC 20307 Phone: 202-782-7341 | |
Lauren Mckelroy, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2141 K St Nw Ste 307, Washington, DC 20037 Phone: 202-293-3990 | |
Dr. Catharine Lisa Kauffman, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3301 New Mexico Ave Nw, Suite #210, Washington, DC 20016 Phone: 202-363-9600 Fax: 202-363-9601 | |
Dr. Melissa Bueche Scorza, M.D Dermatology Medicare: Accepting Medicare Assignments Practice Location: 6900 Georgia Ave Nw, Washington, DC 20307 Phone: 202-782-6173 | |
Dr. Edward H Stolar, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1712 Eye Street Nw, Suite 712, Washington, DC 20006 Phone: 202-659-2223 Fax: 202-659-0289 | |
Dr. Karin Aberg Brooks, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3301 New Mexico Ave Nw Ste 301, Washington, DC 20016 Phone: 022-937-6182 Fax: 916-442-5702 | |
Dr. Clinzo P. Mickle Ii, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 650 Pennsylvania Ave Se, Suite 420, Washington, DC 20003 Phone: 202-547-9001 |